ARU Grand Rounds: Regenerative Medicine for Osteoarthritis – What is the Current Evidence?

Speaker for this CME Activity is Sean Colio, MD

Regenerative Medicine for Osteoarthritis – What is the Current Evidence?

Regenerative medicine for Osteoarthritis is an emerging area that will influence the treatment of joint diseases in the future. It involves the use of biomaterials, cell therapy, and bioactive factors such as growth factors, drugs and small molecules, to regenerate damaged tissues. Dr. Colio will highlight the current evidence that informs on the direction in which this field is moving. This multidisciplinary field has been very active, with rapid development of new technologies.

Desired Outcomes:

• Discuss the History & Biology of Platelet Rich Plasma (PRP)and Mesenchymal Stem Cells (MSC) for Osteoarthritis
• Review the Clinical Applications of Platelet Rich Plasma (PRP)and Mesenchymal Stem Cells (MSC) for Osteoarthritis
• Evaluate the Evidence for Platelet Rich Plasma (PRP)and Mesenchymal Stem Cells (MSC) in Osteoarthritis

Geared to physicians and ancillary clinical staff.

CME Activity Flyer (PDF)